Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation

Nikhil R. Thiruvengadam; Kimberly A. Forde; Vinay Chandrasekhara; Nuzhat A. Ahmad; Gregory G. Ginsberg; Vandana Khungar; Michael L. Kochman

doi:10.1016/j.cgh.2019.10.014

Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation

Nikhil R. Thiruvengadam
, Kimberly A. Forde
, Vinay Chandrasekhara
, Nuzhat A. Ahmad
, Gregory G. Ginsberg
, Vandana Khungar
, Michael L. Kochman

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1224-1232.e1
Journal	Clinical Gastroenterology and Hepatology
Volume	18
Issue number	5
DOIs	https://doi.org/10.1016/j.cgh.2019.10.014
State	Published - May 2020
Externally published	Yes

ASJC Scopus Subject Areas

Hepatology
Gastroenterology

Keywords

Anastomotic Strictures
Nonsteroidal Anti-Inflammatory Drug
Post-ERCP Pancreatitis
Prevention
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
Humans
Risk Factors
Administration, Rectal
Cholangiopancreatography, Endoscopic Retrograde/adverse effects
Tacrolimus/adverse effects
Indomethacin/adverse effects
Pancreatitis/prevention & control
Retrospective Studies
Liver Transplantation/adverse effects

Access to Document

10.1016/j.cgh.2019.10.014

OpenUrl availability

Full text

Cite this

Thiruvengadam, N. R., Forde, K. A., Chandrasekhara, V., Ahmad, N. A., Ginsberg, G. G., Khungar, V., & Kochman, M. L. (2020). Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation. Clinical Gastroenterology and Hepatology, 18(5), 1224-1232.e1. https://doi.org/10.1016/j.cgh.2019.10.014

Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation. / Thiruvengadam, Nikhil R.; Forde, Kimberly A.; Chandrasekhara, Vinay et al.
In: Clinical Gastroenterology and Hepatology, Vol. 18, No. 5, 05.2020, p. 1224-1232.e1.

Research output: Contribution to journal › Article › peer-review

Thiruvengadam, NR, Forde, KA, Chandrasekhara, V, Ahmad, NA, Ginsberg, GG, Khungar, V & Kochman, ML 2020, 'Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation', Clinical Gastroenterology and Hepatology, vol. 18, no. 5, pp. 1224-1232.e1. https://doi.org/10.1016/j.cgh.2019.10.014

Thiruvengadam NR, Forde KA, Chandrasekhara V, Ahmad NA, Ginsberg GG, Khungar V et al. Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation. Clinical Gastroenterology and Hepatology. 2020 May;18(5):1224-1232.e1. doi: 10.1016/j.cgh.2019.10.014

@article{0ed884374a1149f4b33c6c4f70c24a9a,

title = "Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation",

keywords = "Anastomotic Strictures, Nonsteroidal Anti-Inflammatory Drug, Post-ERCP Pancreatitis, Prevention, Anti-Inflammatory Agents, Non-Steroidal/adverse effects, Humans, Risk Factors, Administration, Rectal, Cholangiopancreatography, Endoscopic Retrograde/adverse effects, Tacrolimus/adverse effects, Indomethacin/adverse effects, Pancreatitis/prevention \& control, Retrospective Studies, Liver Transplantation/adverse effects",

author = "Thiruvengadam, \{Nikhil R.\} and Forde, \{Kimberly A.\} and Vinay Chandrasekhara and Ahmad, \{Nuzhat A.\} and Ginsberg, \{Gregory G.\} and Vandana Khungar and Kochman, \{Michael L.\}",

note = "Publisher Copyright: {\textcopyright} 2020 AGA Institute",

year = "2020",

month = may,

doi = "10.1016/j.cgh.2019.10.014",

language = "English",

volume = "18",

pages = "1224--1232.e1",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

number = "5",

}

TY - JOUR

T1 - Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation

AU - Thiruvengadam, Nikhil R.

AU - Forde, Kimberly A.

AU - Chandrasekhara, Vinay

AU - Ahmad, Nuzhat A.

AU - Ginsberg, Gregory G.

AU - Khungar, Vandana

AU - Kochman, Michael L.

PY - 2020/5

Y1 - 2020/5

KW - Anastomotic Strictures

KW - Nonsteroidal Anti-Inflammatory Drug

KW - Post-ERCP Pancreatitis

KW - Prevention

KW - Anti-Inflammatory Agents, Non-Steroidal/adverse effects

KW - Humans

KW - Risk Factors

KW - Administration, Rectal

KW - Cholangiopancreatography, Endoscopic Retrograde/adverse effects

KW - Tacrolimus/adverse effects

KW - Indomethacin/adverse effects

KW - Pancreatitis/prevention & control

KW - Retrospective Studies

KW - Liver Transplantation/adverse effects

UR - https://www.scopus.com/pages/publications/85083067610

UR - https://www.scopus.com/pages/publications/85083067610#tab=citedBy

UR - https://www.mendeley.com/catalogue/a3ea9fc8-830e-3040-995a-c66e5fe9ee5a/

U2 - 10.1016/j.cgh.2019.10.014

DO - 10.1016/j.cgh.2019.10.014

M3 - Article

C2 - 31622734

AN - SCOPUS:85083067610

SN - 1542-3565

VL - 18

SP - 1224-1232.e1

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 5

ER -

Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this